FDA Approval Summary: Vorasidenib for <i>IDH</i> -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery

Michael I. Barbato, Amy K. Barone, Stephanie L. Aungst, Claudia P. Miller, Suryatheja Ananthula, Youwei Bi, Yuching Yang, Xiaoxue Li, Ye Xiong, Jianghong Fan, Sarah E. Dorff, Hong Zhao, Hua Zhou, Shan Pradhan, Barbara Scepura, Arup K. Sinha, Maritsa Stephenson, Vishal Bhatnagar, Haleh Saber, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Paul G. Kluetz, Erin Larkins, Nicole Drezner

Open source

DOI: 10.1158/1078-0432.ccr-25-1333
Published: 2025-09-05
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-1333,
  title = {FDA Approval Summary: Vorasidenib for
                    <i>IDH</i>
                    -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery},
  author = {Michael I. Barbato and Amy K. Barone and Stephanie L. Aungst and Claudia P. Miller and Suryatheja Ananthula and Youwei Bi and Yuching Yang and Xiaoxue Li and Ye Xiong and Jianghong Fan and Sarah E. Dorff and Hong Zhao and Hua Zhou and Shan Pradhan and Barbara Scepura and Arup K. Sinha and Maritsa Stephenson and Vishal Bhatnagar and Haleh Saber and Nam Atiqur Rahman and Shenghui Tang and Richard Pazdur and Paul G. Kluetz and Erin Larkins and Nicole Drezner},
  year = {2025},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-1333},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-1333}
}

RIS

TY  - JOUR
TI  - FDA Approval Summary: Vorasidenib for
                    <i>IDH</i>
                    -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery
AU  - Michael I. Barbato
AU  - Amy K. Barone
AU  - Stephanie L. Aungst
AU  - Claudia P. Miller
AU  - Suryatheja Ananthula
AU  - Youwei Bi
AU  - Yuching Yang
AU  - Xiaoxue Li
AU  - Ye Xiong
AU  - Jianghong Fan
AU  - Sarah E. Dorff
AU  - Hong Zhao
AU  - Hua Zhou
AU  - Shan Pradhan
AU  - Barbara Scepura
AU  - Arup K. Sinha
AU  - Maritsa Stephenson
AU  - Vishal Bhatnagar
AU  - Haleh Saber
AU  - Nam Atiqur Rahman
AU  - Shenghui Tang
AU  - Richard Pazdur
AU  - Paul G. Kluetz
AU  - Erin Larkins
AU  - Nicole Drezner
PY  - 2025
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-25-1333
UR  - https://doi.org/10.1158/1078-0432.ccr-25-1333
ER  -

APA

Barbato, M. I., Barone, A. K., Aungst, S. L., Miller, C. P., Ananthula, S., Bi, Y., Yang, Y., Li, X., Xiong, Y., Fan, J., Dorff, S. E., Zhao, H., Zhou, H., Pradhan, S., Scepura, B., Sinha, A. K., Stephenson, M., Bhatnagar, V., Saber, H., Rahman, N. A., Tang, S., Pazdur, R., Kluetz, P. G., Larkins, E., & Drezner, N. (2025). FDA Approval Summary: Vorasidenib for <i>IDH</i> -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-1333

Source records

crossref · retrieved 2026-09-26T21:25:29.352Z